These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7933842)

  • 1. Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats.
    Tsuboi Y; Ishikawa S; Fujisawa G; Okada K; Saito T
    Kidney Int; 1994 Jul; 46(1):237-44. PubMed ID: 7933842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo diuretic effect of a new non-peptide arginine vasopressin antagonist, OPC-31260, in conscious rats.
    Tsuboi Y; Ishikawa S; Fujisawa G; Okada K; Saito T
    J Endocrinol; 1994 Nov; 143(2):227-34. PubMed ID: 7829988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats.
    Fujisawa G; Ishikawa S; Tsuboi Y; Okada K; Saito T
    Kidney Int; 1993 Jul; 44(1):19-23. PubMed ID: 8355461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vasopressin antagonist on water excretion in inferior vena cava constriction.
    Ishikawa S; Saito T; Okada K; Tsutsui K; Kuzuya T
    Kidney Int; 1986 Jul; 30(1):49-55. PubMed ID: 3747342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
    Saito T; Ishikawa S; Abe K; Kamoi K; Yamada K; Shimizu K; Saruta T; Yoshida S
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1054-7. PubMed ID: 9100572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention.
    Bosch-Marcé M; Poo JL; Jiménez W; Bordas N; Leivas A; Morales-Ruiz M; Muñoz RM; Pérez M; Arroyo V; Rivera F; Rodés J
    J Pharmacol Exp Ther; 1999 Apr; 289(1):194-201. PubMed ID: 10087004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term aquaretic efficacy of a selective nonpeptide V(2)-vasopressin receptor antagonist, SR121463, in cirrhotic rats.
    Jiménez W; Gal CS; Ros J; Cano C; Cejudo P; Morales-Ruiz M; Arroyo V; Pascal M; Rivera F; Maffrand JP; Rodés J
    J Pharmacol Exp Ther; 2000 Oct; 295(1):83-90. PubMed ID: 10991964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased vasopressin-mediated renal water reabsorption in rats with compensated liver cirrhosis.
    Jonassen TE; Nielsen S; Christensen S; Petersen JS
    Am J Physiol; 1998 Aug; 275(2):F216-25. PubMed ID: 9691010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats.
    Claria J; Jiménez W; Arroyo V; Guarner F; López C; La Villa G; Asbert M; Rivera F; Rodés J
    Gastroenterology; 1989 Nov; 97(5):1294-9. PubMed ID: 2792662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal water handling in rats with decompensated liver cirrhosis.
    Jonassen TE; Christensen S; Kwon TH; Langhoff S; Salling N; Nielsen S
    Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1101-9. PubMed ID: 11097629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasopressin antagonist improves renal function in a rat model of pneumoperitoneum.
    Dolgor B; Kitano S; Yoshida T; Bandoh T; Ninomiya K; Matsumoto T
    J Surg Res; 1998 Oct; 79(2):109-14. PubMed ID: 9758724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites.
    Claria J; Jiménez W; Arroyo V; La Villa G; López C; Asbert M; Castro A; Gaya J; Rivera F; Rodés J
    Gastroenterology; 1991 Feb; 100(2):494-501. PubMed ID: 1824629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention.
    Bosch-Marcé M; Jiménez W; Angeli P; Leivas A; Clària J; Graziotto A; Arroyo V; Rivera F; Rodés J
    Gastroenterology; 1995 Jul; 109(1):217-23. PubMed ID: 7797019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the V1a/V2-AVP receptor antagonist, Conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites.
    Fernández-Varo G; Ros J; Cejudo-Martín P; Cano C; Arroyo V; Rivera F; Rodés J; Jiménez W
    J Hepatol; 2003 Jun; 38(6):755-61. PubMed ID: 12763368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis.
    Inoue T; Ohnishi A; Matsuo A; Kawai B; Kunihiro N; Tada Y; Koizumi F; Chau T; Okada K; Yamamura Y; Tanaka T
    Clin Pharmacol Ther; 1998 May; 63(5):561-70. PubMed ID: 9630829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of hypoxic brain oedema by the administration of vasopressin receptor antagonist OPC-31260.
    Molnár AH; Varga C; Berkó A; Rojik I; Párducz A; László F; László FA
    Prog Brain Res; 2008; 170():519-25. PubMed ID: 18655905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin receptor antagonist OPC-31260 prevents cerebral oedema after subarachnoid haemorrhage.
    László FA; Varga C; Nakamura S
    Eur J Pharmacol; 1999 Jan; 364(2-3):115-22. PubMed ID: 9932713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An enhanced effect of arginine vasopressin in bradykinin B2 receptor null mutant mice.
    Alfie ME; Alim S; Mehta D; Shesely EG; Carretero OA
    Hypertension; 1999 Jun; 33(6):1436-40. PubMed ID: 10373229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidiuretic effects of a nonpeptide vasopressin V(2)-receptor agonist, OPC-51803, administered orally to rats.
    Nakamura S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Yamamura Y; Mori T; Tominaga M
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1005-11. PubMed ID: 11082435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological profile of orally administered YM087, a vasopressin antagonist, in conscious rats.
    Tomura Y; Tahara A; Tsukada J; Yatsu T; Uchida W; Iizumi Y; Honda K
    Clin Exp Pharmacol Physiol; 1999; 26(5-6):399-403. PubMed ID: 10386228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.